D. G. Jayne, S. Fook, C. Loi, and F. Seow-choen, Peritoneal carcinomatosis from colorectal cancer, Br J Surg, vol.89, pp.1545-1550, 2002.

H. Al-shammaa, Y. Li, and Y. Yonemura, Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, World J Gastroenterol, vol.14, pp.1159-1166, 2008.

B. Sadeghi, C. Arvieux, and O. Glehen, Peritoneal carcinomatosis from nongynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study, Cancer, vol.88, pp.358-363, 2000.

P. H. Sugarbaker, Peritonectomy procedures, Ann Surg, vol.221, pp.247-264, 1995.

V. J. Verwaal, S. Van-ruth, and E. De-bree, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, vol.21, pp.3737-3743, 2003.

O. Glehen, F. Kwiatkowski, and P. H. Sugarbaker, Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study, J Clin Oncol, vol.22, pp.3284-3292, 2004.

V. J. Verwaal, S. Bruin, H. Boot, G. Van-slooten, and H. Van-tinteren, 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, vol.15, pp.2426-2432, 2008.

D. Elias, J. H. Lefevre, and J. Chevalier, Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin, J Clin Oncol, vol.27, pp.681-685, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00378784

O. Glehen, V. Schreiber, and E. Cotte, Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis Arising from Gastric Cancer, Arch Surg, vol.139, pp.20-26, 2004.

O. Glehen, F. N. Gilly, and C. Arvieux, Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy, Ann Surg Oncol, vol.17, pp.2370-2377, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02303675

X. J. Yang, C. Q. Huang, and T. Suo, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial, Ann Surg Oncol, vol.18, pp.1575-1581, 2011.

W. J. Van-driel, S. N. Koole, and K. Sikorska, Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer, N Engl J Med, vol.73, pp.280-281, 2018.

D. Elias, F. Gilly, and F. Quenet, Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy, Eur J Surg Oncol, vol.36, pp.456-462, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00594804

W. Liauw, T. C. Chua, and D. Elias, Early-and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, J Clin Oncol, vol.30, pp.2449-2456, 2012.

T. D. Yan, L. Welch, D. Black, and P. H. Sugarbaker, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma, Ann Oncol, vol.18, pp.827-834, 2007.

B. Malgras, E. Gayat, and O. Aoun, Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study, Ann Surg Oncol, vol.25, pp.3271-3279, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02264137

D. M. Elias, F. Gilly, and O. Glehen, Report of the 110th congress of AFC. Carcinoses péritonéales d'origine digestive et primitive. Monogr l'Association Française Chir Rueil-Malmaison, Fr Wolters Kluver-Arnette, 2008.

L. Ries, M. P. Eisner, and C. L. Kosary, Seer cancer statistics review, 1975.

M. A. Shahir, V. Lemmens, L. V. Van-de-poll-franse, A. C. Voogd, H. Martijn et al., Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: A population-based study, Eur J Cancer, vol.42, pp.3015-3021, 2006.

W. B. Al-refaie, H. M. Parsons, and W. G. Henderson, Major cancer surgery in the elderly: Results from the american college of surgeons national surgical quality improvement program, Ann Surg, vol.251, pp.311-318, 2010.

H. Mueller, M. Hahn, and . Sj, Cytoreductive surgery in the elderly patients--is it feasible?, Hepatogastroenterology, vol.55, pp.2005-2011, 2008.

A. Macrì, E. Saladino, and G. Trimarchi, Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients, In Vivo, vol.25, pp.687-690, 2011.

Y. Klaver, T. C. Chua, D. Hingh, I. Morris, and D. L. , Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis, J Surg Oncol, vol.105, pp.113-118, 2012.

P. Tabrizian, G. Jibara, and B. Shrager, Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly, Surg Oncol, vol.22, pp.184-189, 2013.

J. D. Spiliotis, E. Halkia, V. A. Boumis, D. T. Vassiliadou, A. Pagoulatou et al.,

, Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly

, Int J Surg Oncol, vol.2014, p.987475, 2014.

P. Cascales-campos, J. Gil, and E. Gil, Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients, Eur J Obstet Gynecol Reprod Biol, vol.179, pp.88-93, 2014.

K. I. Votanopoulos, N. A. Newman, and G. Russell, Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years, Survival Benefit at Considerable Morbidity and Mortality

, Ann Surg Oncol, vol.20, pp.3497-3503, 2013.

Y. Huang, N. A. Alzahrani, S. E. Alzahrani, J. Zhao, W. Liauw et al., Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly, World J Surg Oncol, vol.13, pp.1-7, 2015.

S. Beckert, F. Struller, P. Horvath, A. Falcke, A. Königsrainer et al., Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC. Langenbeck's Arch Surg, vol.400, pp.693-698, 2015.

J. Delotte, T. Arias, and O. Guerin, Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women, Acta Obstet Gynecol Scand, vol.94, pp.435-439, 2015.

M. Alyami, P. Lundberg, and V. Kepenekian, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study, Ann Surg Oncol, vol.23, pp.737-745, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02297800

P. A. Cascales-campos, V. López-lópez, and F. C. Muñoz-casares, Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study, Surg Oncol, vol.25, pp.111-116, 2016.

E. Wong, G. Tan, C. Chia, M. Kumar, K. C. Soo et al., Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Asia Pac J Clin Oncol, vol.501, pp.1-10, 2017.

T. Kitai, K. Yamanaka, Y. Miyauchi, and M. Kawashima, Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy, Int J Clin Oncol, vol.22, pp.519-525, 2017.

N. Cigdem-arslan, T. Bisgin, C. Altay, T. Yavuzsen, A. Karaoglu et al., Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?, J Buon, vol.7, pp.77-83, 2018.

S. Naffouje and G. Salti, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index, Anticancer Res, vol.38, pp.441-448, 2018.

T. Dalgleish, J. Williams, and A. Golden, World Health Organization's report on ageing and healt, J Exp Psychol Gen, vol.136, pp.23-42, 2007.

L. Balducci and M. Extermann, Management of Cancer in the Older Person : A Practical Approach, Oncologist, vol.5, pp.224-237, 2000.

J. Esquivel, Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community, Surg Oncol Clin N Am, vol.16, pp.653-666, 2007.

B. Moran, D. Baratti, T. D. Yan, S. Kusamura, and M. Deraco, Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei), J Surg Oncol, vol.98, pp.277-282, 2008.

A. G. Portilla, K. Shigeki, B. Dario, and D. Marcello, The intraoperative staging systems in the management of peritoneal surface malignancy, J Surg Oncol, vol.98, pp.228-231, 2008.

D. Elias, E. Benizri, M. Pocard, M. Ducreux, V. Boige et al., Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer, Eur J Surg Oncol, vol.32, pp.632-636, 2006.

R. Kianmanesh, S. Scaringi, and J. Sabate, Iterative Cytoreductive Surgery Associated With Hyperthermic Intraperitoneal Chemotherapy for Treatment of

, Peritoneal Carcinomatosis of Colorectal Origin With or Without Liver Metastases, Ann Surg, vol.245, pp.597-603, 2007.

D. Dubois and E. Dubois, Clinical calorimetry: Tenth paper a formula to estimate the approximate surface area if height and weight be known, Arch Intern Med, 1916.

C. A. Bellera, M. Rainfray, and S. Mathoulin-pélissier, Screening older cancer patients: First evaluation of the G-8 geriatric screening tool, Ann Oncol, vol.23, pp.2166-2172, 2012.

F. Pamoukdjian, E. Paillaud, and L. Zelek, L'évaluation gériatrique et les scores pronostiques chez le patient âgé atteint de cancer : une aide à la décision thérapeutique ?, Bull Cancer, vol.104, pp.946-955, 2017.

P. Soubeyran, C. Bellera, and J. Goyard, Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study, Plos One, vol.9, p.115060, 2014.

T. A. Sugarbaker, D. Chang, and P. H. Sugarbaker, Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment, Eur J Cancer, vol.35, pp.413-419, 1999.

P. Jacquet and P. H. Sugarbaker, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, pp.359-374, 1996.

K. Washington, 7th Edition of the AJCC Cancer Staging Manual: Stomach, Ann Surg Oncol, vol.17, pp.3077-3079, 2010.

T. Sano and Y. Kodera, Japanese classification of gastric carcinoma, Gastric Cancer, vol.14, pp.101-112, 2011.

P. H. Sugarbaker, Successful management of microscopic residual disease in large bowel cancer, Cancer Chemother Pharmacol, vol.43, pp.15-25, 1999.

A. A. Sarnaik, J. J. Sussman, S. A. Ahmad, B. C. Mcintyre, and A. M. Lowy, Technology for the delivery of hyperthermic intraoperative intraperitoneal chemotherapy: a survey of techniques. Recent Results Cancer Res, vol.169, pp.75-82, 2007.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

, Ann Surg, vol.240, pp.205-213, 2004.

D. Elias, F. Gilly, and F. Boutitie, Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study, J Clin Oncol, vol.28, pp.63-68, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02304753

H. Müller, T. Hotopp, A. Tofeili, and K. Wutke, Systemic Chemotherapy using FLOT -Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of

, Peritoneal Metastasized Gastric Cancer. Hepatogastroenterology, vol.61, pp.703-706, 2014.

E. Elm, . Von, D. G. Altman, M. Egger, S. J. Pocock et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, vol.370, pp.1453-1457, 2007.

R. P. Mcquellon, B. W. Loggie, and A. B. Lehman, Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, Ann Surg Oncol, vol.10, pp.155-162, 2003.

R. Mcquellon, C. Gavazzi, P. Piso, D. Swain, P. Rd et al., Quality of Life and Nutritional Assessment in Peritoneal Surface Malignancy (PSM): Recommendations for Care, pp.300-305, 2008.

J. Faivre, V. Lemmens, V. Quipourt, and A. M. Bouvier, Management and survival of colorectal cancer in the elderly in population-based studies, Eur J Cancer, vol.43, pp.2279-84, 2007.

M. G. Peters, E. K. Bartlett, R. E. Roses, R. R. Kelz, D. L. Fraker et al., Age-Related Morbidity and Mortality with Cytoreductive Surgery, Ann Surg Oncol, vol.22, issue.3, pp.898-904, 2015.

M. Maillet, O. Glehen, and J. Lambert, Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study, Ann Surg Oncol, vol.23, pp.863-869, 2016.

R. A. Devilee, G. A. Simkens, and T. R. Van-oudheusden, Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Ann Surg Oncol, vol.23, pp.2841-2848, 2016.

Y. Zhu, N. Hanna, C. Boutros, and A. Hr, Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for management of peritoneal metastases, J Gastrointest Oncol, vol.4, pp.62-71, 2013.

L. L. Shan, A. Saxena, B. L. Shan, and D. L. Morris, Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis, Surg Oncol, vol.23, pp.199-210, 2014.

D. G. Jayne, S. Fook, C. Loi, and F. Seow-choen, Peritoneal carcinomatosis from colorectal cancer, Br J Surg, vol.89, pp.1545-1550, 2002.

H. Al-shammaa, Y. Li, and Y. Yonemura, Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis, World J Gastroenterol, vol.14, pp.1159-1166, 2008.

B. Sadeghi, C. Arvieux, and O. Glehen, Peritoneal carcinomatosis from nongynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study, Cancer, vol.88, pp.358-363, 2000.

P. H. Sugarbaker, Peritonectomy procedures, Ann Surg, vol.221, pp.247-264, 1995.

V. J. Verwaal, S. Van-ruth, and E. De-bree, Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer, J Clin Oncol, vol.21, pp.3737-3743, 2003.

O. Glehen, F. Kwiatkowski, and P. H. Sugarbaker, Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study, J Clin Oncol, vol.22, pp.3284-3292, 2004.

V. J. Verwaal, S. Bruin, H. Boot, G. Van-slooten, and H. Van-tinteren, 8-Year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, vol.15, pp.2426-2432, 2008.

D. Elias, J. H. Lefevre, and J. Chevalier, Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin, J Clin Oncol, vol.27, pp.681-685, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00378784

O. Glehen, V. Schreiber, and E. Cotte, Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis Arising from Gastric Cancer, Arch Surg, vol.139, pp.20-26, 2004.

O. Glehen, F. N. Gilly, and C. Arvieux, Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy, Ann Surg Oncol, vol.17, pp.2370-2377, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02303675

X. J. Yang, C. Q. Huang, and T. Suo, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial, Ann Surg Oncol, vol.18, pp.1575-1581, 2011.

W. J. Van-driel, S. N. Koole, and K. Sikorska, Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer, N Engl J Med, vol.73, pp.280-281, 2018.

D. Elias, F. Gilly, and F. Quenet, Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy, Eur J Surg Oncol, vol.36, pp.456-462, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00594804

W. Liauw, T. C. Chua, and D. Elias, Early-and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, J Clin Oncol, vol.30, pp.2449-2456, 2012.

T. D. Yan, L. Welch, D. Black, and P. H. Sugarbaker, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma, Ann Oncol, vol.18, pp.827-834, 2007.

B. Malgras, E. Gayat, and O. Aoun, Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study, Ann Surg Oncol, vol.25, pp.3271-3279, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02264137

A. D. Stephens, R. Alderman, and D. Chang, Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique, Ann Surg Oncol, vol.6, pp.790-796, 1999.

O. Glehen, F. Mithieux, and D. Osinsky, Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study, J Clin Oncol, vol.21, pp.799-806, 2003.

D. Elias, D. Goere, and F. Blot, Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after compete cytoreductive surgery: Mortality and morbidity in 106 consecutive patients, Ann Surg Oncol, vol.14, pp.1818-1824, 2007.

D. Elias, O. Glehen, and M. Pocard, A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix, Ann Surg, vol.251, pp.896-901, 2010.

J. Verhulst, Hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin: Influence of perfusion temperature on postoperative outcome and survival. F1000 Research, pp.1-19, 2013.

A. Macri, V. Arcoraci, and V. Belgrano, Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study, Anticancer Res, vol.34, pp.5689-5693, 2014.

M. Desantis, J. L. Bernard, and V. Casanova, Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbeck's Arch Surg, vol.400, pp.37-48, 2015.

G. Passot, D. Vaudoyer, and L. Villeneuve, What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures, J Surg Oncol, vol.113, pp.796-803, 2016.

D. M. Elias, F. Gilly, and O. Glehen, Report of the 110th congress of AFC. Carcinoses péritonéales d'origine digestive et primitive. Monogr l'Association Française Chir Rueil-Malmaison, Fr Wolters Kluver-Arnette, 2008.

L. Ries, M. P. Eisner, and C. L. Kosary, Seer cancer statistics review, 1975.

M. A. Shahir, V. Lemmens, L. V. Van-de-poll-franse, A. C. Voogd, H. Martijn et al., Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: A population-based study, Eur J Cancer, vol.42, pp.3015-3021, 2006.

W. B. Al-refaie, H. M. Parsons, and W. G. Henderson, Major cancer surgery in the elderly: Results from the american college of surgeons national surgical quality improvement program, Ann Surg, vol.251, pp.311-318, 2010.

H. Mueller, M. Hahn, and . Sj, Cytoreductive surgery in the elderly patients--is it feasible?, Hepatogastroenterology, vol.55, pp.2005-2011, 2008.

A. Macrì, E. Saladino, and G. Trimarchi, Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients, In Vivo, vol.25, pp.687-690, 2011.

Y. Klaver, T. C. Chua, D. Hingh, I. Morris, and D. L. , Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis, J Surg Oncol, vol.105, pp.113-118, 2012.

P. A. Cascales-campos, V. López-lópez, and F. C. Muñoz-casares, Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study, Surg Oncol, vol.25, pp.111-116, 2016.

E. Wong, G. Tan, C. Chia, M. Kumar, K. C. Soo et al., Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Asia Pac J Clin Oncol, vol.501, pp.1-10, 2017.

T. Kitai, K. Yamanaka, Y. Miyauchi, and M. Kawashima, Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy, Int J Clin Oncol, vol.22, pp.519-525, 2017.

N. Cigdem-arslan, T. Bisgin, C. Altay, T. Yavuzsen, A. Karaoglu et al., Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?, J Buon, vol.7, pp.77-83, 2018.

S. Naffouje and G. Salti, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index, Anticancer Res, vol.38, pp.441-448, 2018.

P. Tabrizian, G. Jibara, and B. Shrager, Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly, Surg Oncol, vol.22, pp.184-189, 2013.

J. D. Spiliotis, E. Halkia, V. A. Boumis, D. T. Vassiliadou, A. Pagoulatou et al.,

, Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly

, Int J Surg Oncol, vol.2014, p.987475, 2014.

P. Cascales-campos, J. Gil, and E. Gil, Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients, Eur J Obstet Gynecol Reprod Biol, vol.179, pp.88-93, 2014.

K. I. Votanopoulos, N. A. Newman, and G. Russell, Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years, Survival Benefit at Considerable Morbidity and Mortality

, Ann Surg Oncol, vol.20, pp.3497-3503, 2013.

Y. Huang, N. A. Alzahrani, S. E. Alzahrani, J. Zhao, W. Liauw et al., Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly, World J Surg Oncol, vol.13, pp.1-7, 2015.

S. Beckert, F. Struller, P. Horvath, A. Falcke, A. Königsrainer et al., Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC. Langenbeck's Arch Surg, vol.400, pp.693-698, 2015.

J. Delotte, T. Arias, and O. Guerin, Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women, Acta Obstet Gynecol Scand, vol.94, pp.435-439, 2015.

M. Alyami, P. Lundberg, and V. Kepenekian, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study, Ann Surg Oncol, vol.23, pp.737-745, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02297800

L. Balducci and M. Extermann, Management of Cancer in the Older Person : A Practical Approach, Oncologist, vol.5, pp.224-237, 2000.

J. Esquivel, Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community, Surg Oncol Clin N Am, vol.16, pp.653-666, 2007.

B. Moran, D. Baratti, T. D. Yan, S. Kusamura, and M. Deraco, Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei), J Surg Oncol, vol.98, pp.277-282, 2008.

A. G. Portilla, K. Shigeki, B. Dario, and D. Marcello, The intraoperative staging systems in the management of peritoneal surface malignancy, J Surg Oncol, vol.98, pp.228-231, 2008.

D. Elias, E. Benizri, M. Pocard, M. Ducreux, V. Boige et al., Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer, Eur J Surg Oncol, vol.32, pp.632-636, 2006.

R. Kianmanesh, S. Scaringi, and J. Sabate, Iterative Cytoreductive Surgery Associated With Hyperthermic Intraperitoneal Chemotherapy for Treatment of

, Peritoneal Carcinomatosis of Colorectal Origin With or Without Liver Metastases, Ann Surg, vol.245, pp.597-603, 2007.

D. Dubois and E. Dubois, Clinical calorimetry: Tenth paper a formula to estimate the approximate surface area if height and weight be known, Arch Intern Med, 1916.

C. A. Bellera, M. Rainfray, and S. Mathoulin-pélissier, Screening older cancer patients: First evaluation of the G-8 geriatric screening tool, Ann Oncol, vol.23, pp.2166-2172, 2012.

F. Pamoukdjian, E. Paillaud, and L. Zelek, L'évaluation gériatrique et les scores pronostiques chez le patient âgé atteint de cancer : une aide à la décision thérapeutique ?, Bull Cancer, vol.104, pp.946-955, 2017.

P. Soubeyran, C. Bellera, and J. Goyard, Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study, Plos One, vol.9, p.115060, 2014.

T. A. Sugarbaker, D. Chang, and P. H. Sugarbaker, Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment, Eur J Cancer, vol.35, pp.413-419, 1999.

P. Jacquet and P. H. Sugarbaker, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, pp.359-374, 1996.

K. Washington, 7th Edition of the AJCC Cancer Staging Manual: Stomach, Ann Surg Oncol, vol.17, pp.3077-3079, 2010.

T. Sano and Y. Kodera, Japanese classification of gastric carcinoma, Gastric Cancer, vol.14, pp.101-112, 2011.

P. H. Sugarbaker, Successful management of microscopic residual disease in large bowel cancer, Cancer Chemother Pharmacol, vol.43, pp.15-25, 1999.

A. A. Sarnaik, J. J. Sussman, S. A. Ahmad, B. C. Mcintyre, and A. M. Lowy, Technology for the delivery of hyperthermic intraoperative intraperitoneal chemotherapy: a survey of techniques. Recent Results Cancer Res, vol.169, pp.75-82, 2007.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

, Ann Surg, vol.240, pp.205-213, 2004.

D. Elias, F. Gilly, and F. Boutitie, Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study, J Clin Oncol, vol.28, pp.63-68, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02304753

H. Müller, T. Hotopp, A. Tofeili, and K. Wutke, Systemic Chemotherapy using FLOT -Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of

, Peritoneal Metastasized Gastric Cancer. Hepatogastroenterology, vol.61, pp.703-706, 2014.

E. Elm, . Von, D. G. Altman, M. Egger, S. J. Pocock et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, vol.370, pp.1453-1457, 2007.

M. G. Peters, E. K. Bartlett, R. E. Roses, R. R. Kelz, D. L. Fraker et al., Age-Related Morbidity and Mortality with Cytoreductive Surgery, Ann Surg Oncol, vol.22, issue.3, pp.898-904, 2015.

T. Dalgleish, J. Williams, and A. Golden, World Health Organization's report on ageing and healt, J Exp Psychol Gen, vol.136, pp.23-42, 2007.

M. Maillet, O. Glehen, and J. Lambert, Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study, Ann Surg Oncol, vol.23, pp.863-869, 2016.

R. A. Devilee, G. A. Simkens, and T. R. Van-oudheusden, Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Ann Surg Oncol, vol.23, pp.2841-2848, 2016.

Y. Zhu, N. Hanna, C. Boutros, and A. Hr, Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for management of peritoneal metastases, J Gastrointest Oncol, vol.4, pp.62-71, 2013.

L. L. Shan, A. Saxena, B. L. Shan, and D. L. Morris, Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis, Surg Oncol, vol.23, pp.199-210, 2014.